Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

The immediate threat has passed, at least for now. But concern from individuals, businesses, nonprofits and local governments ...

A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...

Canadian scientists say the uncertainty surrounding U.S. President Donald Trump's pause on federal health spending there ...

When research is stopped, or even paused, it has real effects on our lives. It means that a cure for the diabetes that runs in your family will be delayed. It means that efforts to understand how ...

Trump's freeze on federal grants and loans could total trillions of dollars and cause disruptions in health care research, ...

Major academic research institutions and medical schools in the Philadelphia region are allotted $1.7 billion in NIH funding.

A Minnesota mother and son urge action as National Institute of Health restrictions disrupt research vital to Muscular ...

A phase 2 trial finds that for patients with HER2+ metastatic colorectal cancer, dual HER2-inhibitor therapy can be a similarly efficacious but less toxic alternative to EGFR inhibitor therapy.

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

Researchers are worried about the federal cancellation of meetings last week which are key to hundreds of millions in funding ...